The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons (Q42549432)

2 November 2017

title

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons (English)

1 reference

2 November 2017

Mos J

1

1 reference

2 November 2017

Van Hest A

2

1 reference

2 November 2017

Van Drimmelen M

3

1 reference

2 November 2017

Herremans AH

4

1 reference

2 November 2017

Olivier B

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

European Journal of Pharmacology

2 November 2017

published in

1 reference

2 November 2017

volume

325

1 reference

2 November 2017

issue

2-3

1 reference

2 November 2017

page(s)

145-153

1 reference

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Anticonflict effects of the 5-HT1A compound flesinoxan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Serotonin receptors: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

A proposed new nomenclature for 5-HT receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Centrally active 5-HT receptor agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

5-Hydroxytryptamine receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Flesinoxan shows antidepressant activity in a DRL 72-s screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Discriminative stimulus properties of flesinoxan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

Discriminative stimulus effect of flesinoxan: effect of 5-HT1A antagonists and PCPA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900131-3

10.1016/S0014-2999(97)00131-3

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference